Effect of cisapride on gastric emptying in premature infants with feed intolerance

Journal of Paediatrics and Child Health

Volumn 37, Issue 6, 2001, Pages 559-563

  Barnett, C P ^a,b   Omari, T ^a,b   Davidson, G P ^a,b   Goodchild, L ^a,b   Lontis, R ^a,b   Dent, J ^a,b   Haslam, R R ^a,b  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Cisapride; Gastric emptying; Premature infants

Indexed keywords

CISAPRIDE; PLACEBO;

ARTICLE; BREATH ANALYSIS; CHILD GROWTH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; GASTROESOPHAGEAL REFLUX; GESTATIONAL AGE; HUMAN; NEWBORN; NUTRITIONAL INTOLERANCE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH EMPTYING; SYMPTOMATOLOGY; TREATMENT FAILURE; TREATMENT OUTCOME; WEIGHT;

BREATH TESTS; CISAPRIDE; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENTERAL NUTRITION; FEEDING AND EATING DISORDERS OF CHILDHOOD; FEMALE; FOLLOW-UP STUDIES; GASTRIC EMPTYING; GASTROINTESTINAL AGENTS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; MALE; PROBABILITY; REFERENCE VALUES; TREATMENT OUTCOME;

EID: 0035672412     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1754.2001.00705.x     Document Type: Article

References (27)

1. Gastro-esophageal reflux
2. Clinically significant gastroesophageal reflux in the at-risk premature neonate. Relation to cognitive scores, days in the NICU, and total hospital charges
3. Cisapride. A survey of the frequency of use and adverse events in premature newborns
4. The role of cisapride in the treatment of pediatric gastroesophageal reflux
5. The risks and benefits of cisapride in premature neonates, infants, and children
6. Cisapride for gastroesophageal reflux disease: A placebo-controlled, double-blind study
7. Cisapride stimulates human esophageal motility
8. Randomised controlled trial of cisapride in preterm infants
9. Randomised controlled trial of cisapride in feed intolerance in preterm infants
10. Cisapride in the control of symptoms in infants with gastroeophageal reflux: A randomized, double-blind, placebo-controlled trial
11. Cisapride in pediatric gastroesophageal reflux
12. Effects of cisapride on QT interval in children
13. Proarrhythmia associated with cisapride in children
14. Effects of cisapride on QTc interval in neonates
15. Cisapride-induced long QT interval
16. Gastrointestinal motility in the neonate
17. Clinical pharmacokinetics of cisapride
18. Population pharmacokinetics of enterally administered cisapride in young infants with gastro-oesophageal reflux disease
19. 13C-octanoic acid breath test for assessment of gastric emptying in healthy preterm infants
20. 13C-octanoic acid breath test: A noninvasive technique to assess gastric emptying in preterm infants
21. Measurement of gastric emptying rate of solids by means of a carbon-labelled octanoic acid breath test
22. Reflux symptoms in 100 normal infants. Diagnostic validity of the infant gastroesophageal reflux questionnaire
23. Long-term use of cisapride (Prepulsid) in premature neonates of less than 34 weeks gestational age
24. Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease
25. Cisapride: A gastrointestinal prokinetic drug
26. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders
27. Behavior and gastro-oesophageal reflux in the premature neonate